Paediatric rheumatology in 2014: Digging deeper for greater precision and more impact in JIA

Berent Prakken1, Alberto Martini2

  • 1Department of Paediatric Immunology &Laboratory for Translational Immunology, University Medical Centre Utrecht, PO Box 85090, 3508 AB Utrecht, Netherlands.

Insights

Optimizing childhood arthritis management needs personalized disease insights. Genetic studies and immunopathogenesis research in 2014 paved the way for clinical biomarkers and individualized therapy.

Area of Science:

  • Pediatric Rheumatology
  • Immunogenetics
  • Translational Medicine

Background:

  • Effective management of childhood arthritis necessitates a deep understanding of individual patient disease characteristics.
  • Recent advancements are crucial for developing targeted treatment strategies.

Purpose of the Study:

  • To explore how genetic studies and immunopathogenesis insights can inform clinical practice.
  • To highlight the potential for developing individualized therapies for childhood arthritis.

Main Methods:

  • Review of genetic studies published in 2014.
  • Analysis of immunopathogenesis research.
  • Evaluation of the translation of research findings into clinical biomarkers.

Main Results:

  • In-depth genetic investigations offer valuable insights into disease mechanisms.
  • Understanding immunopathogenesis is key to identifying therapeutic targets.
  • The potential for developing clinical biomarkers from these studies is significant.

Conclusions:

  • Advances in genetic and immunopathogenesis research are critical for optimizing childhood arthritis management.
  • These insights are expected to lead to the development of individualized therapeutic approaches.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
991
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
524
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.2K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K